It is known that dehydroepiandrosterone (DHEA) inhibits a phenotypic switch in vascular smooth muscle cells (VSMC) induced by platelet derived growth factor (PDGF)-BB. However, the mechanism behind the effect of DHEA on VSMC is not clear. Previously we reported that low molecular weight-protein tyrosine phosphatase (LMW-PTP) dephosphorylates PDGF receptor (PDGFR)-β via a redox-dependent mechanism involving glutathione (GSH)/glutaredoxin (GRX)1.
DHEA Attenuates PDGF-induced Phenotypic Proliferation of Vascular
play a critical role in the pathogenesis of atherosclerosis. VSMC express a set of smooth muscle-specific genes, which are characteristic of their contractile, differentiated phenotype [1] . VSMC undergo phenotypic modulation in response to environmental signals. Accelerated migration, proliferation, and production of extracellular matrix components by phenotypically modulated VSMC play a central role in the development of atherosclerotic lesions [1] .
Platelet derived growth factors (PDGFs) bind to two cell-surface receptor-tyrosine kinases, PDGF receptor (PDGFR) α and β [2] . PDGF-dependent activation of receptors causes a mitogenic signal transduction through the phosphorylation of specific tyrosines in the receptors [2] [3] [4] .
Dehydroepiandrosterone (DHEA) and the sulfated prohormone of DHEA circulate at higher plasma concentrations than any other steroids. Both the occurrence and the clinical manifestation of coronary atherosclerosis have been inversely correlated with plasma levels of DHEA or DHEA sulfate [5] . DHEA has a wide variety of beneficial biological and physiological effects on the prevention of cardiovascular disease [6] .
The redox status of sulfhydryl groups in proteins plays an important role in the regulation of cellular functions such as the synthesis and folding of proteins and regulation of the structure and activity of enzymes, receptors, and transcription factors [7] . Glutaredoxin (GRX), a glutathione (GSH)-dependent oxidoreductase, catalyzes the reduction of protein disulfide via a disulfide exchange reaction [8] .
Previously, we reported that GRX1 plays an important role in regulating PDGF-BB-dependent signals through down-regulation of the tyrosine phosphorylation of PDGFR-β [3] . The GSH/GRX1 system suppresses the PDGF-BB-induced tyrosine phosphorylation of PDGFR-β, resulting in suppression of the PDGF-BB-dependent cell proliferation. Furthermore, we found a novel regulatory mechanism for PDGF-BB signaling involving the redox-dependent regulation of low molecular weight protein-tyrosine phosphatase (LMW-PTP) by GRX1 in a GSH-dependent manner [3] . Recently, we also reported that estradiol potentiates GSH/GRX1 redox potential in cardiomyocytes through upregulation of the gene expression of γ-glutamylcysteine synthetase, the rate limiting enzyme of GSH synthesis and GRX1 [9] . Then, we were interested in whether DHEA has any effects on the GSH/GRX1 system in VSMC exposed to PDGF-BB. In the present study, we demonstrate that DHEA attenuates PDGF-BB-induced VSMC proliferation and phenotypic modulation. Importantly, we show that DHEA increases the expression of GRX and GSH synthesis. This increase in GSH/GRX1 redox potential stimulates the LMW-PTP to down-regulate the activity for tyrosine phosphorylation of PDGFR-β.
Reagents
Rabbit antibodies against PDGFR-β and phospho (Tyr-751)-PDGFR-β were obtained from Cell Signaling Technology. PDGF-BB, GSH, GSSG, NADPH, 3-(4,5-dimethyl-thiazole-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), flutamide and p-nitrophenyl phosphate were from Sigma Chemical Co.. DHEA, hydrogen peroxide, and dithiothreitol (DTT) were from Wako Pure Chemicals (Osaka, Japan).
Normal goat, rabbit and mouse IgG were from Sigma Chemical Co.
4-Acetamido-4'-maleimidylstilbene-2, 2'-disulfonic acid (AMS) was purchased from Molecular Probes. ICI182,780 was from Tocris (Ballwin, MO).
Cell culture and proliferation.
Rat embryonic thoracic aorta smooth muscle-derived A7r5 cells were obtained from American Type Culture Collection (Manassas, VA) and cultured as described [10] . Briefly, cells were incubated in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum at 37˚C in a humidified atmosphere of 95% air and 5% CO 2 . After the attainment of confluency (70-80%), the cells were incubated in serum-free DMEM containing 0. GST-fused LMW-PTP (GST-LMW-PTP) was affinity purified from cell lysates using glutathione-Sepharose 4B (Amersham Biosciences), and then digested with PreScission protease.
The cleaved GST was removed from the glutathione-Sepharose 4B, and LMW-PTP was purified. The LMW-PTP was used to immunize rabbits to generate anti-LMW-PTP antibodies, and also used for experiments concerning the redox regulation of LMW-PTP as described below.
Immunoblot analysis
Cultured cells were harvested and lysed for 20 min at 4˚C in lysis buffer. The supernatants obtained by centrifugation of the lysates at 8000 x g for 15 min were used in subsequent experiments. Protein concentrations were determined using a BCA assay kit (Pierce). Protein samples were electrophoresed on 10, 12.5 or 15%
SDS-polyacrylamide gels under reducing conditions, except for thiol-modified protein samples. The proteins in the gels were transferred onto nitrocellulose membranes, and were incubated with horseradish peroxidase-conjugated anti-IgG antibodies. Proteins in the membranes were visualized using the enhanced chemiluminescence detection kit (Amersham Biosciences) according to the manufacturer's instructions.
Determination of redox states.
The redox states of proteins were assessed by modifying free thiol with AMS [11] . Briefly, after incubation with or without PDGF-BB, cell lysates or proteins were treated with trichloroacetic acid at a final concentration of 7.5% to denature and precipitate the proteins as well as to avoid any subsequent redox reactions. The protein precipitates were collected by centrifugation at 12000 x g for 10 min at 4˚C.
The pellets were rinsed in acetone and centrifuged twice, then, dissolved in a buffer containing 50 mM Tris-HCl (pH7.4), 1% SDS and 15 mM AMS. Proteins were then separated by 10% SDS-PAGE without using any reducing agents and blotted to nitrocellulose membranes. Proteins in the membranes were treated with 5% (w/v) nonfat dry milk and 0.1% Tween 20 in TBS solution for 1 h at room temperature, then further kept overnight at 4˚C for visualization by immunoblotting as described above.
Determination of cellular glutathione levels.
GSH and glutathione disulfide (GSSG) levels were measured as described previously [9] using a Total Glutathione Quantification Kit (Dojindo Molecular
Technologies, Inc, MD) according to the manufacturer's directions.
Generation of luciferase reporter constructs.
A 2.0-kb fragment of the human GRX1 gene promoter (-2023 to -22) was amplified by PCR using Pfu turbo DNA polymerase (Stratagene). The primers used were /5'-GGA CTG AGT GAG AGG CAG ACA ATA GTC TCC -3'/ as a forward primer, and /5'-CGG GAA GAA TCC TCA GTT GCA GGT ATT GCT TGG -3'/ as a reverse primer. The PCR product was subcloned into pUC18 to obtain pUC18-pro-GRX. PUC18-pro-GRX was digested with HindIII, and the resulting fragment containing the promoter region from -2023 to -22 was inserted into the HindIII site of the reporter vector pGL3-Basic (Stratogene) to give pGL3-pro-GRX.
To generate a deleted form of the luciferase reporter construct (pGL3-pro-GRX-del), pGL3-pro-GRX was digested with KpnI and PvuII (Takara Biomedicals).
Site-directed mutagenesis for luciferase vectors was performed with pGL3-pro-GRX (-2023 to -22) as a template by using a QuickChange site-directed mutagenesis kit containing a PPRE-like domain; AGATCACAGGTCA. It was annealed using a forward sequence (5'-gac ggt acc AGA TCA CAG GTC ATT GAT AAG ATC ACA GGT Cag tgg agc tc-3') and a reverse sequence (5-'gag ctc cac TGA CCT GTG ATC TTA TCA ATG ACC TGT GAT CTg gta ccg tc-3'). The annealed product was subcloned into pUC18 to obtain pUC18-pro-γ-GCS. pUC18-pro-γ -GCS was digested with Kpn I and Sac I. The resulting fragment containing the promoter region (-10625 ~-10613) was inserted into the HindIII site of the reporter vector pGL3-Basic to give pGL3-pro-γ-GCS. To generate a deleted version of the luciferase reporter construct (pGL3-pro-γ-GCS-del), pGL3-pro-γ-GCS was digested with KpnI and PvuII. Site-directed mutagenesis for luciferase vectors was performed with pGL3-pro-γ-GCS as a template.
Luciferase activity assay.
Each vector was introduced into A7r5 cells by using Lipofectamine 2000
(Invitrogen) according to the manufacturer's instructions. The luciferase activity was assayed with cellular extracts by using a luciferase reporter assay system (Promega).
Quantitative RT-PCR.
Quantitative RT-PCR was performed using the One Step SYBR® RT-PCR kit 
Statistical analysis
Data were presented as the mean ± SD. Differences were examined by using ANOVA (StatView software). A value of P < 0.05 was considered significant.
RESULTS AND DISCUSSION

DHEA suppresses PDGF-induced proliferation of A7r5 cells
The effect of DHEA on PDGF-induced cell proliferation was examined in A7r5 cells. Serum-starved A7r5 cells were cultured with or without 100 nM DHEA for 18 h, then in medium containing 0.2% FBS with or without 2 nM PDGF-BB. As shown in Figure 1A 
Suppression of VSMC marker genes by PDGF-BB is restored by DHEA
Next, the effect of DHEA on the expression of VSMC marker genes was examined. As VSMC marker genes, SMα-actin and SM22α were estimated by the quantitative RT-PCR method. After incubation with or without 100 nM DHEA for 18 h, A7r5 cells were treated with 2 nM PDGF-BB for 24 h. As shown in Figure 1C , the expression of SM22α and SMα-actin was suppressed by treatment with PDGF-BB, whereas the suppressive effect of PDGF-BB on the VSMC phenotype was restored by DHEA. Taken together, DHEA attenuates the PDGF-induced proliferation and phenotypic switch in VSMC, suggesting that DHEA has some effects on the PDGF-BB-dependent cell signaling. Then, PDGF-BB-induced phosphorylation of PDGFR-β was examined.
DHEA down-regulates the PDGF-BB-dependent phosphorylation of PDGFR-β
PDGFR-β -mediated signals are particularly important for vascular remodeling and neointima formation [13] . As shown in Figure 2A Treatment with DHEA increased GRX1 mRNA and γ-GCS, a rate-limiting enzyme for GSH synthesis ( Figure 2C ). The level of GSH was increased by DHEA, while the level of GSSG was not changed by DHEA, resulting in the high GSH/GSSG ratio ( Figure 2D ). These results indicate that DHEA increases the expression of GRX1
and γ-GCS to elevate the GSH/GRX1 redox potential as well as the GSH/GSSG ratio.
DHEA-dependent promoter activity of GRX1 and γ-GCS gene is regulated by
PPARα DHEA upregulates the transcriptional activity mediated by PPARα [14, 15] .
This mechanism involves upregulation of the expression of PPARα mRNA by DHEA [15] . To investigate the transcriptional regulation of GRX1 and γ-GCS by DHEA via the PPARα-binding domain, a luciferase vector containing PPRE-like domain was constructed and introduced into A7r5 cells. The luciferase activity of the cells treated with DHEA for 18 h showed a 1.8-fold increase, but was almost lost when the PPRE-like site was deleted or mutated ( Figure 3A) . Deletion of EpRE-like 2 or SP1 had no apparent effect on the DHEA-induced up-regulation of the luciferase activity (data not shown). Similarly, the promoter region of the γ-GCS heavy subunit containing a PPRE-like site was inserted into a luciferase vector. The luciferase activity of the cells treated with DHEA was stimulated by 1.6 fold, but was lost when the PPRE-like site was mutated ( Figure 3B ). The results suggest that PPARα plays a role in the DHEA-induced up-regulation of the expression of GRX1
and γ-GCS.
DHEA maintained the redox state of LMW-PTP
PDGFR is a receptor-type tyrosine kinase, the activation of which is regulated by PDGF-dependent autophosphorylation and dephosphorylation by protein tyrosine phosphatases (PTPs). A number of tyrosine residues are phosphorylated in the cytosolic domain of PDGFR, leading to a site-specific recruitment of signal transduction molecules [4] . PTPs such as LMW-PTP are implicated in the control of PDGFR phosphorylation [16] . LMW-PTP is an 18-kDa enzyme that is widely expressed [17] . We focused on LMW-PTP because its redox-dependent regulation and the role in PDGF-BB/PDGFR signaling have been studied extensively [4] .
Oxidative stress generated by PDGF-BB/PDGFR-β-mediated signaling causes the oxidization of LMW-PTP to form dithiothreitol-reducible high molecular weight oligomers, and the generation of peroxide is involved in the downregulation of LMW-PTP activity by PDGF-BB, leading to the activation of PDGFR-BB-dependent signaling pathways [3] . Figure 4A shows that a decrease in the reduced form of LMW-PTP (the active form) was observed on treatment with PDGF-BB for 30 min In this experiment, oligomerized LMW-PTP (the inactive form) was not detectable for unknown reason, and LMW-PTP-specific phosphatase activity was not determined. Together with our previous report using synthesized LMW-PTP and GSH/GRX1 redox system [3] , the data suggest that DHEA maintained the redox state of LMW-PTP regulated by the GSH/GRX1 system.
Transfection of siRNAs for GRX1 and LMW-PTP abolishes the effect of DHEA on PDGF-BB-induced phosphorylation of PDGFR-β
To down-regulate the expression of GRX1 and LMW-PTP, specific siRNA (100 nM) were introduced into A7r5 cells. siRNAs bearing scrambled sequences were PDGF-BB-induced proliferation of VSMC is independent of the androgen receptor and estrogen receptor [12] .
In summary, this study showed that DHEA inhibits PDGFR-β phosphorylation that leads to proliferation and phenotypic changes of VSMC, and that the transcriptional control of the GSH/GRX level and the redox state of LMW-PTP may account, at least in part, for the beneficial effects of DHEA on VSMC.
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